Drug recall · December 17, 2014
Fluoxetine Capsules USP recall
Why: Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01
- Lots / codes
Lot ET5122, Exp. 10/17
- Quantity
- 1,008 bottles
- Company
- Sandoz Incorporated, Broomfield, CO
- Distribution
- AZ
- Initiated
- December 5, 2014 · Voluntary: Firm initiated
- Classified
- December 9, 2014
- Reported
- December 17, 2014
- Ended
- June 24, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluoxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.